Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 Apr;9(4):432–434. doi: 10.1111/j.1365-2125.1980.tb01074.x

The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum.

F J Rowell, S M Hui, A F Fairbairn, D Eccleston
PMCID: PMC1429973  PMID: 7378262

Full text

PDF
432

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crane G. E. Factors predisposing to drug-induced neurologic effects. Adv Biochem Psychopharmacol. 1974;9(0):269–279. [PubMed] [Google Scholar]
  2. Kobayashi R. M. Drug therapy of tardive dyskinesia. N Engl J Med. 1977 Feb 3;296(5):257–260. doi: 10.1056/NEJM197702032960506. [DOI] [PubMed] [Google Scholar]
  3. Nyberg G., Axelsson R., Mårtensson E. Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. Eur J Clin Pharmacol. 1978 Dec 18;14(5):341–350. doi: 10.1007/BF00611904. [DOI] [PubMed] [Google Scholar]
  4. Rowell F. J., Hui S. M., Paxton J. W. The evaluation of a radioimmunoassay for phenothiazines and thioxanthenes using an iodinated tracer. J Immunol Methods. 1979;31(1-2):159–166. doi: 10.1016/0022-1759(79)90296-5. [DOI] [PubMed] [Google Scholar]
  5. Snyder S. H. Receptors, neurotransmitters and drug responses. N Engl J Med. 1979 Mar 1;300(9):465–472. doi: 10.1056/NEJM197903013000904. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES